Skip to main content
Erschienen in: Indian Journal of Pediatrics 11/2017

02.06.2017 | Scientific Letter

Urine Incontinence Induced by Valproic Acid

verfasst von: Yeeshu Singh Sudan, Atma Ram Bansal

Erschienen in: Indian Journal of Pediatrics | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor: Being a broad spectrum antiepileptic drug (AED), Valproic acid (VPA) is one of the most common used AED in day-to-day practice. Urinary incontinence per se is rarely reported as a side-effect of VPA. We have observed four cases over the last two years of OPD practice (Table 1). Three patients had recurrent generalized tonic-clonic seizures (GTCS) with normal developmental milestones, clinical examination and MRI brain indicating benign epilepsy. One patient was found to have symptomatic focal epilepsy. These patients were started on VPA from the treating pediatricians. Within a span of few weeks to two months, they presented with nocturnal incontinence with or without day-time incontinence. VPA does were as per body weight (15–33 mg/kg/d); however serum levels were not monitored. There was no reported fever or burning micturition and routine blood and urine tests were normal. Subsequent to discontinuation of therapy with VPA, there was no urinary incontinence.
Table 1
Patient details
 
Age/Sex
Onset of epilepsy
Type of seizure
Type of epilepsy
Duration of VPA therapy before the onset of incontinence
Dose of VPA
1
11 y/ F
2.5 y
GTCS
Idiopathic/ Genetic
2 mo
15 mg/kg/d
2
11 y/M
10.8 y
GTCS
Idiopathic/ Genetic
10 d
25 mg/kg/d
3
5.5 y/F
4 y
GTCS
Probable genetic epilepsy
Immediate
20 mg/kg/d
4
6 y/M
4.5 y
Focal
Symptomatic epilepsy
1 mo
33 mg/kg/d
M Male; F Female; GTCS Generalized tonic-clonic seizure; VPA Valproic acid; y years; mo months; d days
Literatur
1.
Zurück zum Zitat Sandyk R. Urinary incontinence associated with clonazepam therapy. S Afr Med J. 1983;64:230.PubMed Sandyk R. Urinary incontinence associated with clonazepam therapy. S Afr Med J. 1983;64:230.PubMed
2.
Zurück zum Zitat Hmouda H, Salem CB, Grira M, Slim R, Bouraoui K. Carbamazepine-induced urinary retention. Br J Clin Pharmacol. 2007;64:833–4.PubMedPubMedCentral Hmouda H, Salem CB, Grira M, Slim R, Bouraoui K. Carbamazepine-induced urinary retention. Br J Clin Pharmacol. 2007;64:833–4.PubMedPubMedCentral
3.
Zurück zum Zitat Malik AM, Usmani A. Day time urinary incontinence due to valproate in a patient with idiopathic generalized tonic clonic seizures. J Case Rep. 2013;3:53–5.CrossRef Malik AM, Usmani A. Day time urinary incontinence due to valproate in a patient with idiopathic generalized tonic clonic seizures. J Case Rep. 2013;3:53–5.CrossRef
4.
Zurück zum Zitat Incecik F, Herguner OM, Besen S, Altunbasak S. Urinary and fecal incontinence during levetiracetam therapy. Ann Indian Acad Neurol. 2015;18:479–80.PubMedPubMedCentral Incecik F, Herguner OM, Besen S, Altunbasak S. Urinary and fecal incontinence during levetiracetam therapy. Ann Indian Acad Neurol. 2015;18:479–80.PubMedPubMedCentral
5.
Zurück zum Zitat Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.CrossRefPubMed Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.CrossRefPubMed
Metadaten
Titel
Urine Incontinence Induced by Valproic Acid
verfasst von
Yeeshu Singh Sudan
Atma Ram Bansal
Publikationsdatum
02.06.2017
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 11/2017
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-017-2387-0

Weitere Artikel der Ausgabe 11/2017

Indian Journal of Pediatrics 11/2017 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.